In this study, we performed high-throughput transcriptomic analysis of neuroblastoma, ganglioneuroma, and ganglioneuroblastoma samples and identified the lncRNA ADAMTS9 antisense RNA 2 (ADAMTS9-AS2) as a critical regulator in the differentiation of neuroblastoma. The gene discussed is ADAMTS9; the disease is ganglioneuroma.